Severe COVID-19-induced AKI: a 3-month follow-up

Publié en avril 2021 Clinical Kidney Journal

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

Clinical Kidney Journal

Publication précédente

Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease

Clinical Kidney Journal

Publication suivante

Auteurs

Arthur Orieux
Sébastien Rubin
Renaud Prevel
Antoine Garric
Didier Gruson
Alexandre Boyer